The availability of references and the sponsorship of original research cited in pharmaceutical advertisements
- HIGH COMPRESSION MARKETING SUPERCHARGES DRUG REVENUES. Loden, D. John; Liebman, Milton // Medical Marketing & Media;Mar2000, Vol. 35 Issue 3, p66
Reports that United states pharmaceutical companies, motivated by high research costs and short patent life, utilize `high compression marketing' to drive new drug brand share higher and faster. Success factors for a quick-time blockbuster, as in the case of Celebrex; Includes qualities the...
- MORE ON DRUG COMPANY DECEPTIONS AND ABUSES. Rosch, Paul J. // Health & Stress;2002, Issue 7, p1
Reports the advertising deception and abuse issues of drug companies in the U.S. Implications of direct advertising for drug costs and patient pressures; Comparison of funded heart drug on safety and efficacy; Expenditures of drug companies on unethical prescription of products.
- Prescription drug advertising soars through third quarter. // Medical Marketing & Media;Feb99, Vol. 34 Issue 2, p22
Reports on the growth of direct-to-consumer advertising of prescription drugs in the United States, for the first three quarters of 1998. Percentage of growth from 1997 figures; Total advertising expenditures of the drug industry.
- Seniors flunk DTC retention. // Medical Marketing & Media;Apr99, Vol. 34 Issue 4, p44
Reports that nearly 300 men aged 60-75 have failed to retain product risk information in direct-to-consumer drug advertisements the United States.
- DTC ads send 19 percent to the doctor. // Medical Marketing & Media;Apr99, Vol. 34 Issue 4, p48
Reports on the effects of pharmaceutical direct-to-consumer advertisements in the United States.
- Antidepressants perk up journal media schedules, jerk up managed care costs. // Medical Marketing & Media;Oct99, Vol. 34 Issue 10, p18
Reports on drug advertising in medical and professional journals in the United States, for the quarter ended May 1999. Leading categories of advertised drugs; Growth in use of prescription drugs during the period; Increases in pharmacy benefit costs in 1998.
- 1999 PERQ/HCI HEALTHCARE ADVERTISING REVIEW. May, Eugene M. // Medical Marketing & Media;Apr2000, Vol. 35 Issue 4, p60
Presents a review of advertising revenues of United States specialty pharmaceutical sectors for 1999. Absence of double-digit figures for individual market gainers; Decline of advertising expenditures in the pharmacy and hospital management sectors; Growth of optometry and ophthalmology...
- Pharmaceutical company outlay tops $8 billion in first half 2000. // Medical Marketing & Media;Dec2000, Vol. 35 Issue 12, p23
Reports on the increase in the promotional spending of pharmaceutical companies in the United States during the first two quarters of 2000. Breakdown of promotional expenditures; Companies with the highest promotional expenses.
- DTC advertising driving brand awareness. // Medical Marketing & Media;Nov98, Vol. 33 Issue 11, p42
Focuses on the benefits of direct-to-consumer (DTC) advertising on drug companies. Increased drug brand awareness of consumers due to DTC advertising campaigns.